Boston Scientific is a Buy with a $109 target and 14% upside from strong demand, Q3 beats, raised FY25 guidance, and growth ...
I believe the 7,550 level is more likely where the bellwether index will finish in 2026. This figure reflects a 14.4% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback